Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial

Objective Proactive therapeutic drug monitoring (pTDM) intends to optimise tumour necrosis factor (TNF) inhibitor treatment through regular assessment of drug and antidrug antibody levels, enabling individualised dosing. However, health economic evidence for this strategy is limited. This study aims...

Полное описание

Библиографические подробности

Главные авторы:	Tore K Kvien, Joseph Sexton, Espen A Haavardsholm, Sella A Provan, Jorgen Jahnsen, Eline Aas, Nils Bolstad, Ivar S Kristiansen, Johanna Elin Gehin, Silje Watterdal Syversen, Guro Løvik Goll, Kristin Kaasen Jørgensen, Teresa Holly, Marthe Kirkesaether Brun, Gunhild Hagen
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMJ Publishing Group 2026-03-01
Серии:	RMD Open
Online-ссылка:	https://rmdopen.bmj.com/content/12/1/e006329.full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!